The Drug Regulatory Authority of Pakistan (DRAP) has made 2D barcodes mandatory for locally produced and imported medicines.
All medicines manufactured or imported on or after October 9, 2026, must carry a unique 2D Data Matrix barcode and serial number.
DRAP has introduced this requirement under its Pharmaceutical Track and Trace System.
The system will help authorities monitor medicines as they move from manufacturers and importers to distributors and sellers.
Which medicines to have 2D barcodes?
According to DRAP, the new requirement applies to both locally manufactured and imported pharmaceutical products.
It also covers medicines used for humans and animals.
However, medicines manufactured or imported before October 9, 2026, are exempt from the new rule.
These older batches can still be imported, distributed and sold legally.
DRAP has instructed manufacturers and importers to follow the technical requirements set out in the relevant regulations.
The authority has also warned that companies violating the rules could face legal action.
How will the new barcode system work?
The new system will give medicines unique identification details, helping authorities track products throughout the supply chain.
DRAP says the technology will make it easier to identify counterfeit, falsified and unregistered medicines.
DRAP has also consulted pharmaceutical companies and importers about implementing the system, including the Pakistan Pharmaceutical Manufacturers’ Association, Pharma Bureau and medicine importers.
The authority plans to introduce the tracking system in phases, and let consumers to scan the 2D codes on medicine packaging to check product authenticity also.
The authority hopes to reduce the circulation of unsafe products and strengthen public trust.